<!DOCTYPE html SYSTEM "about:legacy-compat"><html lang="en-US" data-colors-preset="contrast" data-primary-color="#307FFF"><head><meta http-equiv="Content-Type" content="text/html; charset=UTF-8"><meta charset="UTF-8"><meta name="robots" content="noindex">  <meta name="built-on" content="2024-01-01T13:15:31.3581696"><meta name="build-number" content="${buildNumber}">       <title>持续的收入增长和强劲的盈利能力 惠誉将药明康德评级展望由&ldquo;稳定&rdquo;调整至&ldquo;正面&rdquo; | 2023-10-18</title><script id="virtual-toc-data" type="application/json">[]</script><script id="topic-shortcuts" type="application/json"></script><link href="https://resources.jetbrains.com/writerside/apidoc/6.6.6-b205/app.css" rel="stylesheet">   <link rel="apple-touch-icon" sizes="180x180" href="https://jetbrains.com/apple-touch-icon.png"><link rel="icon" type="image/png" sizes="32x32" href="https://jetbrains.com/favicon-32x32.png"><link rel="icon" type="image/png" sizes="16x16" href="https://jetbrains.com/favicon-16x16.png"><link rel="manifest" href="https://jetbrains.com/site.webmanifest"><link rel="mask-icon" href="https://jetbrains.com/safari-pinned-tab.svg" color="#000000"><meta name="msapplication-TileColor" content="#000000"/><meta name="msapplication-TileImage" content="https://resources.jetbrains.com/storage/ui/favicons/mstile-144x144.png"/><meta name="msapplication-square70x70logo" content="https://resources.jetbrains.com/storage/ui/favicons/mstile-70x70.png"/><meta name="msapplication-square150x150logo" content="https://resources.jetbrains.com/storage/ui/favicons/mstile-150x150.png"/><meta name="msapplication-wide310x150logo" content="https://resources.jetbrains.com/storage/ui/favicons/mstile-310x150.png"/><meta name="msapplication-square310x310logo" content="https://resources.jetbrains.com/storage/ui/favicons/mstile-310x310.png"/>  <meta name="image" content=""><!-- Open Graph --><meta property="og:title" content="持续的收入增长和强劲的盈利能力 惠誉将药明康德评级展望由&ldquo;稳定&rdquo;调整至&ldquo;正面&rdquo; | 2023-10-18"/><meta property="og:description" content=""/><meta property="og:image" content=""/><meta property="og:site_name" content="2023-10-18 Help"/><meta property="og:type" content="website"/><meta property="og:locale" content="en_US"/><meta property="og:url" content="7034.html"/><!-- End Open Graph --><!-- Twitter Card --><meta name="twitter:card" content="summary_large_image"><meta name="twitter:site" content=""><meta name="twitter:title" content="持续的收入增长和强劲的盈利能力 惠誉将药明康德评级展望由&ldquo;稳定&rdquo;调整至&ldquo;正面&rdquo; | 2023-10-18"><meta name="twitter:description" content=""><meta name="twitter:creator" content=""><meta name="twitter:image:src" content=""><!-- End Twitter Card --><!-- Schema.org WebPage --><script type="application/ld+json"> { "@context": "http://schema.org", "@type": "WebPage", "@id": "7034.html#webpage", "url": "7034.html", "name": "持续的收入增长和强劲的盈利能力 惠誉将药明康德评级展望由&ldquo;稳定&rdquo;调整至&ldquo;正面&rdquo; | 2023-10-18", "description": "", "image": "", "inLanguage":"en-US" }</script><!-- End Schema.org --><!-- Schema.org WebSite --><script type="application/ld+json"> { "@type": "WebSite", "@id": "/#website", "url": "/", "name": "2023-10-18 Help" }</script><!-- End Schema.org --></head>      <body data-id="7034" data-main-title="持续的收入增长和强劲的盈利能力 惠誉将药明康德评级展望由&ldquo;稳定&rdquo;调整至&ldquo;正面&rdquo;" data-article-props="{&quot;seeAlsoStyle&quot;:&quot;links&quot;}"  data-template="article"  data-breadcrumbs=""  >   <div class="wrapper"><main class="panel _main"><header class="panel__header"><div class="container"><h3>2023-10-18  Help</h3><div class="panel-trigger"></div></div></header><section class="panel__content"><div class="container"><article class="article" data-shortcut-switcher="inactive"><h1 data-toc="7034"   id="7034.md">持续的收入增长和强劲的盈利能力 惠誉将药明康德评级展望由&ldquo;稳定&rdquo;调整至&ldquo;正面&rdquo;</h1>  <p id="517d42b5_7"><span class="control" id="517d42b5_8">2023-10-18 00:45</span></p><p id="517d42b5_9"><span class="control" id="517d42b5_10">https://www.gelonghui.com/live/1251279</span></p><p id="517d42b5_11">格隆汇10月18日｜10月17日，惠誉发布评级报告将药明康德长期发行人违约评级（IDR）的展望从稳定调整为正面。并进一步确认药明康德长期IDR和高级无抵押评级为BBB。 惠誉表示，积极的展望反映了我们的预期。未来药明康德在强劲的经营现金流的推动下，公司2024年自由现金流将继续保持为正值。其持续增长的收入以及强劲的盈利能力将使其产生自由现金流的能力持续增强。评级也反映了药明康德独特的CRDMO和CTDMO业务模式在全球医药研发外包行业的领先地位。</p><div class="last-modified"> Last modified: 01 一月 2024</div><div data-feedback-placeholder="true"></div><div class="navigation-links _bottom">  <a class="navigation-links__prev" href="7035.html">特斯拉呼吁美国政府提高燃油经济标准，取消电动汽车积分制度</a>   <a class="navigation-links__next" href="7033.html">社保基金现身11只股前十大流通股东榜，李子园持股量占流通股比例7.85%居首</a>  </div></article><div id="disqus_thread"></div></div></section></main></div>  <script src="https://resources.jetbrains.com/writerside/apidoc/6.6.6-b205/app.js"></script></body></html>